Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Naturecell Co., Ltd. (007390:KRX), powered by AI.
Naturecell Co., Ltd. is currently trading at ₩20,100. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Naturecell Co., Ltd. on Alpha Lenz.
Naturecell Co., Ltd.'s P/E ratio is 1053.2.
“Naturecell Co., Ltd. trades at a P/E of 1053.2 (premium valuation) with modest ROE of 1.9%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Naturecell Co., Ltd. is a biotechnology company primarily focused on the development, production, and commercialization of cell therapy products. The company operates in the burgeoning biopharmaceutical industry, aiming to leverage stem cell technologies to offer innovative treatment options for a range of medical conditions. It engages in research and development efforts to create therapies that can enhance regenerative processes in the human body, particularly targeting diseases that currently have limited treatment avenues. Naturecell Co., Ltd. is dedicated to advancing therapeutic solutions that can address unmet medical needs, potentially impacting healthcare outcomes significantly. The company’s presence in the market underscores the growing importance of biotechnology and regenerative medicine in modern healthcare. By investing in cutting-edge research and employing advanced biotechnologies, Naturecell Co., Ltd. plays a critical role in the evolution of medical treatments, positioning itself as a key player in the sector. With its focus on innovation and the application of cell therapy, the firm contributes to the broader objective of developing sustainable and effective healthcare solutions worldwide.
“Naturecell Co., Ltd. trades at a P/E of 1053.2 (premium valuation) with modest ROE of 1.9%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Naturecell Co., Ltd. (ticker: 007390) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $1.3T.
The current price is ₩20,100 with a P/E ratio of 1,053.16x and P/B of 19.98x.
ROE is 1.95% and operating margin is 1.87%. Annual revenue is $32.3B.